CJC-1295 IPAMORELIN BLEND (NO DAC) 5MG/5MG Lab Bundles
$ 96.47
CJC-1295 Ipamorelin Lab Bundle — GH-Axis Research Peptide 5mg CJC-1295 Ipamorelin Lab Bundle Overview CJC-1295 Ipamorelin lab bundle is designed for labs and researchers that need reliable access to the same peptide in higher quantities. Available in 5-pack and 10-pack case options, each bundle contains 5mg vials of CJC-1295 Ipamorelin research peptide blend. Built-in volume savings, streamlined ordering, and consistent lot numbers support easier record-keeping across research programs. All products are supplied in secure, clearly labeled vials and are intended strictly for research use only — not for human use, diagnostic, or therapeutic applications. CJC-1295 (NO DAC) combined with Ipamorelin is a widely studied dual-pathway GH-axis research model. It pairs a GHRH analog (CJC-1295 NO DAC) with a selective GHSR-1a agonist (Ipamorelin). In controlled laboratory environments, CJC-1295 Ipamorelin lab bundle is used to investigate synergistic GH-release mechanisms and pituitary signaling pathways. Studies also examine hypothalamic-pituitary integration, metabolic-axis regulation, and peptide-driven endocrine modulation across in-vitro and animal-model research systems. Representative Literature — CJC-1295 Ipamorelin Lab Bundle (Independent GHRH / GHSR / GH-Axis Signaling Research | Research Use Only) The publications below provide general scientific context on GHRH analogs, ghrelin-receptor signaling, and GH-axis biology. They do not involve CJC-1295, Ipamorelin, or Novaglo Research products and must not be interpreted as evidence of safety, efficacy, or suitability for human use. GHRH & GH-Axis Signaling Mayo K.E. et al. “GHRH receptor biology and pituitary signaling.” Endocr Rev. Gaylinn B.D. “Structure and function of GHRH analogs.” Growth Horm IGF Res. Ghrelin-Receptor (GHSR-1a) Pathways Kojima M. et al. “Ghrelin receptor signaling mechanisms.” Nature. Holst B. et al. “GHSR-1a activation and intracellular pathways.” J Biol Chem. Neuroendocrine Integration Müller E.E. et al. “Hypothalamic-pituitary regulation of GH secretion.” Physiol Rev. Steyn F.J. et al. “Neuroendocrine control of pulsatile GH release.” J Endocrinol. Discovery Context CJC-1295: Early 2000s Ipamorelin: 1998 For research use only. Not for human consumption.





